A 
Agilent Technologies A · USD
Health Care · Life Sciences Tools & Services · US listing · 🇺🇸 United States
S&P 500
180.17
+3.10%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$6.95bn
FY2016FY2025
Net income
$1.30bn
FY2016FY2025
Free cash flow
$1.15bn
FY2016FY2025
Shareholders' equity
$6.74bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.95bn | $6.51bn | $6.83bn | $6.85bn | $6.32bn | $5.34bn | $5.16bn | $4.91bn | $4.47bn | $4.20bn |
| Gross profit | $3.64bn | $3.54bn | $3.46bn | $3.72bn | $3.41bn | $2.84bn | $2.81bn | $2.69bn | $2.41bn | $2.20bn |
| Research and development | $455.0m | $479.0m | $481.0m | $467.0m | $441.0m | $495.0m | $404.0m | $385.0m | $339.0m | $329.0m |
| Operating income | $1.48bn | $1.50bn | $1.35bn | $1.62bn | $1.43bn | $846.0m | $941.0m | $941.0m | $841.0m | $615.0m |
| Net income | $1.30bn | $1.29bn | $1.24bn | $1.25bn | $1.21bn | $719.0m | $1.07bn | $316.0m | $684.0m | $460.0m |
| Diluted earnings per share | 4.59 | 4.43 | 4.23 | 4.21 | 3.97 | 2.31 | 3.42 | 0.98 | 2.12 | 1.40 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $12.73bn | $11.85bn | $10.76bn | $10.53bn | $10.71bn | $9.63bn | $9.45bn | $8.54bn | $8.43bn | $7.82bn |
| Cash and short-term investments | $1.79bn | $1.33bn | $1.59bn | $1.05bn | $1.57bn | $1.44bn | $1.38bn | $2.25bn | $2.68bn | $2.29bn |
| Total liabilities | $5.99bn | $5.95bn | $4.92bn | $5.23bn | $5.32bn | $4.75bn | $4.70bn | $3.97bn | $3.59bn | $3.57bn |
| Debt | $3.35bn | $3.39bn | $2.73bn | $2.77bn | $2.73bn | $2.36bn | $2.41bn | $1.80bn | $2.01bn | $1.90bn |
| Shareholders' equity | $6.74bn | $5.90bn | $5.84bn | $5.30bn | $5.39bn | $4.87bn | $4.75bn | $4.57bn | $4.83bn | $4.24bn |
| Shares outstanding | 284m | 291m | 293m | 298m | 305m | 311m | 313m | 322m | 323m | 328m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $1.56bn | $1.75bn | $1.77bn | $1.31bn | $1.49bn | $921.0m | $1.02bn | $1.09bn | $889.0m | $793.0m |
| Capital spending | −$407.0m | −$378.0m | −$298.0m | −$291.0m | −$189.0m | −$119.0m | −$156.0m | −$177.0m | −$176.0m | −$139.0m |
| Free cash flow | $1.15bn | $1.37bn | $1.47bn | $1.02bn | $1.30bn | $802.0m | $865.0m | $910.0m | $713.0m | $654.0m |
| Dividends paid | −$282.0m | −$274.0m | −$265.0m | −$250.0m | −$236.0m | −$222.0m | −$206.0m | −$191.0m | −$170.0m | −$150.0m |
Latest quarters
By quarter end
| Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.88bn | $1.83bn | $1.80bn | $1.86bn | $1.74bn | $1.67bn | $1.68bn | $1.70bn |
| Gross profit | $1.04bn | $1.01bn | $946.0m | $964.0m | $914.0m | $866.0m | $899.0m | $916.0m |
| Operating income | $444.0m | $411.0m | $363.0m | $443.0m | $372.0m | $300.0m | $376.0m | $408.0m |
| Net income | $362.0m | $339.0m | $305.0m | $434.0m | $336.0m | $215.0m | $318.0m | $351.0m |
| Diluted earnings per share | 1.28 | 1.20 | 1.08 | 1.53 | 1.18 | 0.76 | 1.12 | 1.21 |
| Cash from operations | $519.0m | $277.0m | $268.0m | $545.0m | $362.0m | $221.0m | $431.0m | $481.0m |
| Capital spending | −$80.0m | −$93.0m | −$93.0m | −$93.0m | −$103.0m | −$114.0m | −$97.0m | −$93.0m |
| Free cash flow | $439.0m | $184.0m | $175.0m | $452.0m | $259.0m | $107.0m | $334.0m | $388.0m |
| Total assets | $13.97bn | $13.06bn | $12.81bn | $12.73bn | $12.23bn | $12.16bn | $11.91bn | $11.85bn |
| Cash and short-term investments | $1.76bn | $1.81bn | $1.76bn | $1.79bn | $1.53bn | $1.49bn | $1.47bn | $1.33bn |
| Debt | $3.95bn | $3.35bn | $3.35bn | $3.35bn | $3.41bn | $3.50bn | $3.36bn | $3.43bn |
| Shareholders' equity | $7.36bn | $7.12bn | $6.91bn | $6.74bn | $6.37bn | $6.14bn | $6.03bn | $5.90bn |
Financial ratios
Data as of 21 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 52.4% | 54.3% | 50.7% | 54.4% | 53.9% | 53.1% |
| Operating margin | 21.3% | 23.1% | 19.8% | 23.6% | 22.6% | 15.8% |
| Net margin | 18.8% | 19.8% | 18.1% | 18.3% | 19.1% | 13.5% |
| Return on equity | 19.3% | 21.9% | 21.2% | 23.6% | 22.5% | 14.8% |
| Return on assets | 10.2% | 10.9% | 11.5% | 11.9% | 11.3% | 7.5% |
| Free cash flow yield | 4.4% | 4.7% | 4.5% | 3.4% | 3.5% | 2.1% |
| Revenue growth | 6.7% | -4.7% | -0.2% | 8.4% | 18.4% | 3.4% |
| Earnings growth | 1.1% | 4.0% | -1.1% | 3.6% | 68.3% | -32.9% |
| Current ratio | 1.96x | 2.09x | 2.61x | 2.03x | 2.22x | 2.33x |
| Debt to equity | 0.50x | 0.58x | 0.48x | 0.52x | 0.52x | 0.48x |
| Equity ratio | 53.0% | 49.8% | 54.3% | 50.4% | 50.3% | 50.6% |
| Interest coverage | 13.21x | 15.67x | 14.21x | 19.26x | 17.60x | 10.85x |
| R&D as a share of sales | 6.5% | 7.4% | 7.0% | 6.8% | 7.0% | 9.3% |
| Buybacks as a share of market value | 2.4% | 0.7% | 1.7% | 2.3% | 1.9% | 0.6% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 0.5% | 5.4% | 5.6% |
| Operating income | -2.9% | 11.8% | 11.0% |
| Net income | 1.3% | 12.6% | 12.5% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 53.3% | 52.9% | 53.1% | 53.2% |
| Operating margin | 22.2% | 21.9% | 21.2% | 19.6% |
| Net margin | 19.3% | 18.7% | 18.1% | 16.2% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 29.7 | 30.3 | 32.9 | 35.6 | 40.2 | 51.3 | 24.9 | 68.7 | 31.6 | 32.5 |
| Price to sales | 5.6 | 6.0 | 6.0 | 6.5 | 7.7 | 6.9 | 5.2 | 4.4 | 4.8 | 3.6 |
Market value over time
31 Oct 2016 to 18 Sept 2026, in USD
$14.29bn$44.28bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 3% | -5% | -5% | -2% | 28% | 38% | 31% | -3% | 46% | 14% |
Dividends and splits
Per share, in the currency the company pays
Paid for 14 years. Last went ex-dividend on 6 Oct 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 1.02 | 0.992 | 0.944 | 0.90 | 0.84 | 0.776 | 0.72 | 0.656 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.